Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. Jun 17, 2008; 98(12): 1934–1943.
Published online May 27, 2008. doi:  10.1038/sj.bjc.6604396
PMCID: PMC2441968

Are one or two simple questions sufficient to detect depression in cancer and palliative care? A Bayesian meta-analysis

Abstract

The purpose of this study is to examine the value of one or two simple verbal questions in the detection of depression in cancer settings. This study is a systematic literature search of abstract and full text databases to January 2008. Key authors were contacted for unpublished studies. Seventeen analyses were found. Of these, 13 were conducted in late stage palliative settings. (1) Single depression question: across nine studies, the prevalence of depression was 16%. A single ‘depression' question enabled the detection of depression in 160 out of 223 true cases, a sensitivity of 72%, and correctly reassured 964 out of 1166 non-depressed cancer sufferers, a specificity of 83%. The positive predictive value (PPV) was 44% and the negative predictive value (NPV) 94%. (2) Single interest question: there were only three studies examining the ‘loss-of-interest' question, with a combined prevalence of 14%. This question allowed the detection of 60 out of 72 cases (sensitivity 83%) and excluded 394 from 459 non-depressed cases (specificity of 86%). The PPV was 48% and the NPV 97%. (3) Two questions (low mood and low interest): five studies examined two questions with a combined prevalence of 17%. The two-question combination facilitated a diagnosis of depression in 138 of 151 true cases (sensitivity 91%) and gave correct reassurance to 645 of 749 non-cases (specificity 86%). The PPV was 57% and the NPV 98%. Simple verbal methods perform well at excluding depression in the non-depressed but perform poorly at confirming depression. The ‘two question' method is significantly more accurate than either single question but clinicians should not rely on these simple questions alone and should be prepared to assess the patient more thoroughly.

Keywords: depression, diagnostic validity, meta-analysis, sensitivity

There is a general consensus that it is important to recognise and treat depression during the course of cancer, especially in palliative stages where particular emphasis is on quality of life (Stiefel et al, 2001; Noorani and Montagnini, 2007). Distress, anxiety and depression powerfully influence quality of life as well as satisfaction with care and participation in medical treatment (Skarstein et al, 2000; Stark et al, 2002; Kennard et al, 2004; Bui et al, 2005). Studies that have used structured psychiatric interviews suggest that the median prevalence of major depressive disorder is 15% in advanced cancer (Hotopf et al, 2002). Four large-scale studies using severity scales suggest that the overall prevalence of distress in unselected cancer patients is above 30% (Pascoe et al, 2000; Fallowfield et al, 2001; Zabora et al, 2001; Carlson et al, 2004). Yet, it is well known that syndromal anxiety and depression are often overlooked by busy cancer professionals in palliative and non-palliative settings (Ford et al, 1994; Fallowfield et al, 2001; Sollner et al, 2001; Stiefel et al, 2001; Durkin et al, 2003; Sharpe et al, 2004) and the majority of patients will not gain access to mental health services (Kadan-Lottick et al, 2005). In part, this is because cancer specialists have difficulty in identifying emotional complications and tend to have communication behaviours that systematically focus on physical rather than psychological concerns (Durkin et al, 2003).

More than 50 questionnaires have been developed to aid the detection of depression or severe distress, but most have been validated in primary care rather than cancer settings (Lloyd-Williams et al, 2003b). Perhaps, best known of all depression scales is the Patient Health Questionnaire (in either nine or two item forms) (Spitzer et al, 1999). This scale has some merit in primary care and appears highly acceptable (Mitchell and Coyne, 2007) but has yet to be rigorously tested in cancer settings. Indeed, only a handful of tools have been studied specifically in palliative care (Le Fevre et al, 1999; Holtom and Barraclough, 2000; Lloyd-Williams et al, 2001, 2004; Love et al, 2004; Thekkumpurath et al, 2007). Their main limitation, however, is that they are often too long for routine use (Mitchell et al, 2008). In response to this problem, short versions of many common depression scales have been developed. These include 7 and 6 item versions of the Hamilton Depression Rating Scale (HAMD) (McIntyre et al, 2005; Guo et al, 2006; Serrano-Duen and Soledad, 2008); 13, 7 and 2 item versions of the Beck Depression Inventory (BDI) (Steer et al, 1999; Furlanetto et al, 2005; Huffman et al 2006); 13, 10 and 6 item versions of the Center for Epidemiologic Studies Depression Scale (CES-D) (Burnam et al, 1988; Cole et al, 2004; Covic et al, 2007); 5, 4 and 2 item versions of the Geriatric Depression Scale (GDS) (Andresen et al, 1994; van Marwijk et al, 1995; Hoyl et al, 1999); and 8, 6 and 5 item versions of the Edinburgh Depression scale (EPDS) (Pallant et al, 2006; Eberhard-Gran et al, 2007; Lloyd-Williams et al, 2007). Occasionally, authors have developed entirely new short scales, such as the four item case-find for depression (Jefford et al, 2004), or attempted to develop a short scale specifically for palliative settings (Lloyd-Williams et al, 2007).

In the 1990s, several groups working in cancer settings suggested that two questions, or in some cases just a single question, might be sufficient to detect depression in palliative care. Usually, these ultra-short tests formed part of symptom checklists and were not validated against an accepted standard (Miller and Walsh, 1991; Donnelly et al, 1995; Conill et al, 1997; Brunelli et al, 1998; Edmonds et al, 1998; Ng and von Gunten, 1998; Pratheepawanit et al, 1999). At the same time, simple (non-verbal) visual-analogue methods of assessing depression, anxiety or distress were developed, exemplified by the NCCN Distress Thermometer and Edmonton Symptom Assessment (Hürny et al, 1996; Vignaroli et al, 2006). The accuracy of these methods was reviewed in mixed cancer settings with the finding that they had reasonable rule-out accuracy but limited case-finding ability (Mitchell, 2007). Yet, it is not clear how simple verbal questions perform alone and when used specifically for patients with advanced cancer.

The aim of this study is to examine the diagnostic accuracy of simple verbal questions to detect depression in cancer and palliative care and to ascertain whether clinicians should rely upon either one question or two questions to detect major depression compared with more established screening tools.

MATERIALS AND METHODS

Search

A systematic literature search, critical appraisal of the collected studies and pooled analysis were conducted. The following abstract databases were searched: Medline 1966-January 2008, PsycINFO 1887-January 2008, Embase 1980-January 2008 and CINAHL 1982-January 2008. In these databases, the keywords (MeSH terms) were ‘distress or anxi$ or depress$ or mood' and ‘screen$ or detect$ or case-finding or recogni$ or diagnos$ or recogni$' and ‘cancer or oncology or malignant or transplant or tumour or metastatic.' Four full text collections including Science Direct, Ingenta Select, Ovid Full text and Wiley Interscience were searched. In these online databases, the same search terms were used but as a full text search and citation search. The abstract database Web of Knowledge (4.0, ISI) was searched, using the above terms as a text word search, and using key papers in a reverse citation search. Conference abstracts from IPOS 2006 and 2007 were examined. Non-English language papers and abstracts were included but, where necessary, authors were contacted directly for primary data and data in press.

Critical appraisal

The review guidelines for diagnostic tests recently outlined in Evidence Based Medicine were followed (Pai et al, 2004). Questions for each report included the setting, the data integrity, the choice of reference criterion, the method of application of the screening questionnaire and, importantly, the type of outcome measured. Quality appraisal standards are listed in Table 1.

Table 1
Methodological aspects of simple verbal questions for depression in cancer

Pooled analysis and meta-analysis

Two methods are possible in combining diagnostic validity studies (Midgette et al, 1993; Irwig et al, 1995). (a) Simple pooling of the raw data and re-calculation of the cumulative sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). This method assumes a consistent prevalence between studies and in future work. (b) Correction for the variance in prevalence by relying on the stability of sensitivity and specificity by calculating a pooled weighted rate of sensitivity and specificity and then calculating PPV and NPV according to local prevalence data (Glasziou and Irwig, 1998). In this case, a Bayesian curve can be constructed of all post-test probabilities if a given test is positive or negative. Overall accuracy was calculated using the identificiation index which is the fraction correct minus faction incorrect. The reciprocal of the identification index is the number needed to screen (Mitchell, 2009).

Standards of accuracy

Performance was taken as follows: <0.2 poor, >0.2[less-than-or-eq, slant]0.4 fair, >0.4[less-than-or-eq, slant]0.6 moderate, >0.6[less-than-or-eq, slant]0.8 good and >0.8[less-than-or-eq, slant]1 very good; adapted from that originally proposed by Landis and Koch (Landis and Koch, 1977).

Outcome measures

The majority of studies defined depression using a psychiatric interview (applied in a semistructured or clinical interview) but a minority utilised standardised rating scales (Murphy, 2002).

RESULTS

Systematic literature search

The search identified 98 analyses specifically examining ultra-short methods (Figure 1). Studies that examined one or two question methods in non-cancer medical patients or in primary care were excluded. A total of 39 studies had no gold standard and 29 examined visual-analogue methods and were therefore excluded. Thirteen studies were not sufficiently detailed for inclusion. Thus, 17 analyses of verbal/written questions to detect depression in cancer were included. No attempt was made to separate questions read by investigators (verbal) from questions read by the patients (written). The data extraction is illustrated in Figure 1 in accordance with Quality of Reporting of Meta-analyses guidelines (Moher et al, 1999).

Figure 1
Quorom diagram of studies.

Of 17 analyses, 9 examined one single depression question: Chochinov et al (1997); Lloyd-Williams et al (2003a); Meyer et al (2003a); Jefford et al (2004); Akechi et al (2006); Kawase et al (2006); Ohno et al (2006); Payne et al (2007); and Mitchell et al (2008). Three analyses examined one single interest item: Akechi et al (2006); Payne et al (2007); and Mitchell et al (2008). Five analyses examined a combination of two questions: Akechi et al (2006); 65 Payne et al (2007); Chochinov et al (1997); Gessler et al (2007); and Mitchell et al (2008).

Critical appraisal

The mean sample size was 165.8 (s.d. 55.7). However, several studies examined different verbal methods in the same sample and thus there were actually 1579 unique patients under study. Eleven studies took place in palliative settings and/or specifically in those with late-stage cancer. Three took place in mixed stages and three in predominantly early cancers. All but two studies used DSM criteria by clinical interview or by structured clinical interview. Four looked at major or minor depression combined and the remainder looked at major depression alone.

The most common question for depression was simply ‘Are you depressed?' but variations included ‘Describe your mood over the last week' and the PHQ2 question two ‘Over the last 2 weeks, how often have you been bothered by feeling down, depressed or hopeless?' The loss of interest question was asked in three different ways, namely ‘Have you lost interest?', ‘Have you experienced loss of interest in things or activities that you would normally enjoy?' and the PHQ2 question one ‘Over the last 2 weeks, how often have you been bothered by little interest or pleasure in doing things?' The two-question approach was always asked as question 1 (Q1) or question 2 (Q2), which favours sensitivity at the expense of specificity compared to the Q1 and Q2 approach (Coyne and Mitchell, 2007). Further details of the studies are shown in Tables 1 and and22.

Table 2
Statistical summary of simple verbal questions for depression in cancer

Pooled analysis and meta-analysis

Single depression/mood question

Across nine studies, the prevalence of depression was 16%. Using the simple pooled method, the single depression question enabled the detection of depression in 160 out of 223 true cases, a sensitivity of 72% (95% CI 66.3–76.8%) and correctly reassured 964 out of 1166 non-depressed cancer sufferers, a specificity of 83% (95% CI 81.6–83.6). Thus, the PPV was 44% and the NPV was 94%. The Youden score was 0.544 (95% CI 47.9–60.3). Using the meta-analytic approach, the weighted sensitivity was 74.1% (95% CI=0.68–0.80) and the specificity was 85.8% (95% CI 83.7–87.7).

Analysing the results by natural frequencies, out of every 100 screening applications, the single depression question would correctly rule out 69 non-depressed, rule in 11 out of 18 cases, missing 5 and also giving 15 false-positive diagnoses (Figure 2). Thus, the identification index (net gain) would be 61.8% and the number needed to screen in order to yield one additional correct identification would be 1.62.

Figure 2
Natural screening accuracy of simple verbal questions in the detection of cancer-related depression.

Single interest question

There were only three studies examining the ‘loss-of-interest' question, with a pooled prevalence of 14%. Using the simple pooled method, this question allowed the detection of 60 out of 72 cases (sensitivity 83%) (95% CI 74.2–89.9) and excluded 394 from 459 non-depressed cases (specificity of 86%) (95% CI 84.4–89.9). The PPV was 48% and the NPV 97%. The Youden score was 0.692 (95% CI 0.586–0.768). Using the meta-analytic approach, the weighted sensitivity was 82.4% (95% CI=73.0–90.0) and the specificity was 86.4 (95% CI=83.0–89.3).

Analysing the results by natural frequencies, out of every 100 screening applications, the single loss of interest question would correctly rule out 74 non-depressed, rule in 11 out of 14 cases, missing 2 and also giving 12 false-positive diagnoses (Figure 2). Thus, the identification index (net gain) would be 71% and the number needed to screen in order to yield one additional correct identification would be 1.41.

Two questions (low mood and low interest)

In five studies using a two-question combination (Q1 or Q2), the prevalence of depression was 17%. Using the simple pooled method, the two-question combination facilitated a diagnosis of depression in 138 of 151 true cases (sensitivity 91.4%) (95% CI 86.4–94.8) and gave correct reassurance to 645 of 749 non-cases (specificity 86%) (95% CI 85.1–86.8). The PPV was 57% and the NPV 98%. The Youden score was 0.775 (95% CI 0.771–0.816), significantly higher than either of the single questions used alone. Using the meta-analytic approach, the weighted sensitivity was 92.7% (95% CI=88.1–96.3) and specificity 87.4% (95% CI=84.9–89.7).

Analysing the results by natural frequencies, out of every 100 screening applications, these two questions would correctly rule out 72 non-depressed, rule in 15 out of 18 cases, overlooking 1 true case and also giving 12 false-positive diagnoses (Figure 2). Thus, the identification index (net gain) would be 74% and the number needed to screen in order to yield one additional correct identification would be 1.35.

Bayesian pre-test–post-test gain

Assuming sensitivity and specificity hold for different rates of depression, a Bayesian curve was constructed of all post-test probabilities where a test result was either positive or negative. This illustrates the pre-test–post-test gain for each method and the predictive value conditional upon different baseline rates of depression. Figure 3 demonstrated the superior difference in gain for the two-question approach with the depression question alone.

Figure 3
Bayesian graph: test probability (PPV and NPV) as function of test result – depression question vs combination question.

CONCLUSIONS

A previous pooled analysis found eight diagnostic validity analyses of one or two single item questions in the detection of depression in cancer settings (Mitchell, 2007). This study updates the previous analysis to include 17 analyses, 13 involving late-stage cancer and/or palliative settings. It is important to note that the average prevalence of depression across these studies was 16% (range 7–38%), which means that any case-finding method is likely to have difficulty detecting true cases without generating false positives. Results show that the loss of interest question is somewhat better than the depression question when used alone. This corresponds to research showing that, of many symptoms of depression, loss of interest best discriminated between patients with and without diagnosis of comorbid affective disorder (Reuter et al, 2004). However, two questions are significantly better than any one question for detecting depression (Youden score was 0.78 for two questions, 0.54 for the depression question and 0.69 for the interest question). In fact, two questions are better for both ruling in and ruling out a diagnosis than either question alone, although the loss of interest question is also an excellent method of excluding depression. No method achieved a case-finding accuracy of more than 60% according to the PPVs. This means that at best there would be 43 false positives out of each 100 positive screens.

There has been increasing interest in short verbal and non-verbal screening methods. Lloyd-Williams and colleagues (Lawrie et al, 2004) found that among consultants working in palliative medicine, 10% asked the patient ‘are you depressed' to detect depression. Mitchell et al (2008) and colleagues found that simple verbal questions were the most preferred active method of detecting depression, used by 30% of cancer professionals. However, this meta-analysis raises an important caution for all those using one or two questions. Assuming use of the two-question combination, this would mean that out of every 100 screening applications answering yes to either of these two questions, only 1 true case would be missed but 12 false-positive diagnoses would be generated (Figure 2). Thus, a second method with better PPV would be required. This could be a thorough clinical assessment by someone confidently able to diagnose depression or it could be a longer validated depression severity scale (Robinson and Crawford, 2005). However, there is no agreement on which is the optimal case-finding method and rarely has any method shown a case-finding (PPV) accuracy that exceeds 0.80. (Lloyd-Williams et al, 2003b; Trask, 2004). There is also no agreement on how often a tool should be applied (Lloyd-Williams and Riddleston, 2002). For example, Love et al (2004) found that the HADS depression subscale had a PPV of 0.79 when a cut-off of 7v8 was used. Using the same cut-off, Le Fevre et al (1999) found a PPV of 0.42 in a palliative settings. Recently, Lloyd-Williams et al (2007) showed that a six-item adaptation of the EPDS had a PPV of 0.65, also in a palliative setting.

In conclusion, no method has been shown to be sufficiently accurate to be considered the definitive screening or case-finding tool for cancer-related depression. Simple questions should be considered as a method of exclusion or combined with more detailed tests. Future work should move beyond screening for psychopathology alone to also consider unmet needs. That is, those individuals with emotional disorders (distress, anxiety, depression and anger) who require and desire professional help (Graves et al, 2007).

Acknowledgments

Declaration: I have no declarations, no conflicts of interest and no financial ties. I have received no grant support for this article. Thanks to the following individuals who very kindly supplied original data: Elisabeth Andritsch, Elisabeth Ladinek & Silke Zloklikovits, Medical University Graz, Austria; Greg Carter & Catherine Adams, Newcastle Mater Hospital, Australia; Joe Low, Marie Curie Palliative Care Research Unit, London; Anja Mehnert, Hamburg Germany; Anna Szekely, Eötvös Loránd University, Budapest. Thanks also to Elena Baker-Glenn for helpful comments and suggestions.

References

  • Akechi T, Okuyama T, Sugawara Y, Shima Y, Furukawa TA, Uchitomi Y. Screening for depression in terminally ill cancer patients in Japan. J Pain Symptom Manage. 2006;31:5–12. [PubMed]
  • Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale) Am J Prev Med. 1994;10 2:77–84. [PubMed]
  • Brunelli C, Costantini M, Di Giulio P, Gallucci M, Fusco F, Miccinesi G, Paci E, Peruselli C, Morino P, Piazza M, Tamburini M, Toscani F. Quality-of-life evaluation: when do terminal cancer patients and health care providers agree. J Pain Symptom Manage. 1998;15:151–158. [PubMed]
  • Bui Q-UT, Ostir GV, Kuo YF, Freeman J, Goodwin JS. Relationship of depression to patient satisfaction: findings from the barriers to breast cancer study. Breast Cancer Res Treat. 2005;89 1:23–28. [PubMed]
  • Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care. 1988;26:775–789. [PubMed]
  • Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, MacRae JH, Martin M, Pelletier G, Robinson J, Simpson JSA, Speca M, Tillotson L, Bultz B. High levels of untreated distress and fatigue in cancer patients. Br J Cancer. 2004;90:2297–2304. [PMC free article] [PubMed]
  • Chochinov HM, Wilson KG, Enns M, Lander S. ‘Are you depressed?' Screening for depression in the terminally ill. Am J Psychiatr. 1997;154:674–676. [PubMed]
  • Cole JC, Rabin AS, Smith TL, Kaufman AS. Development and validation of a Rasch-derived CES-D short form. Psychological Assessment. 2004;16 4:360–372. [PubMed]
  • Conill C, Verger E, Henriquez I, Saiz N, Espier M, Lugo F, Garrigos A. Symptom prevalence in the last week of life. J Pain Symptom Manage. 1997;14:328–331. [PubMed]
  • Covic T, Pallant JF, Conaghan PG, Tennant A. A longitudinal evaluation of the Center for Epidemiologic Studies-Depression scale (CES-D) in a rheumatoid arthritis population using Rasch analysis. Health Qual Life Outcomes. 2007;5:41. [PMC free article] [PubMed]
  • Coyne JC, Mitchell AJ. NICE may be discouraging detection of postpartum depression. BMJ. 2007;334 7593:550. [PMC free article] [PubMed]
  • Donnelly S, Walsh D, Rybicki L. The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care. 1995;11:27–32. [PubMed]
  • Durkin I, Kearney M, O'Siorain L. Psychiatric disorder in palliative care. Palliat Med. 2003;17:212–218. [PubMed]
  • Eberhard-Gran M, Eskild A, Samuelsen SO, Tambs K. A short matrix-version of the Edinburgh Depression Scale. Acta Psychiatr Scand. 2007;116:195–200. [PubMed]
  • Edmonds PM, Stuttaford JM, Peny J, Lynch AM, Chamberlain J. Do hospital palliative care teams improve symptom control? Use of a modified STAS as an evaluation tool. Palliat Med. 1998;12:345–351. [PubMed]
  • Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 2001;84:1011–1015. [PMC free article] [PubMed]
  • Ford S, Fallowfield L, Lewis S. Can oncologists detect distress in their out-patients and how satisfied are they with their performance during bad news consultations. Br J Cancer. 1994;70:767–770. [PMC free article] [PubMed]
  • Furlanetto L, Mendlowicz M, Bueno JR. The validity of the Beck Depression Inventory-Short Form as a screening and diagnostic instrument for moderate and severe depression in medical inpatients. J Affect Disord. 2005;86 1:87–91. [PubMed]
  • Gessler S, Low J, Daniells E, Williams R, Brough V, Tookman A, Jones L. Screening for distress in cancer patients: is the distress thermometer a valid measure in the UK and does it measure change over time? A prospective validation study Psychooncology 2007. October 31 [Epub ahead of print] [PubMed]
  • Glasziou P, Irwig L. Meta-analysis of diagnostic tests Encyclopedia of Biostatistics 1998. Indianapolis: Wiley; 2579–2585.2585In: Armitage P, Colton T (eds)
  • Graves KD, Arnold SM, Love CL, Kirsh KL, Moore PG, Passik SD. Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer. 2007;55 2:215–224. [PMC free article] [PubMed]
  • Guo Y, Musselman DL, Manatunga AK, Gilles N, Lawson KC, Porter MR, McDaniel JS, Nemeroff CB. The diagnosis of major depression in patients with cancer: a comparative approach. Psychosomatics. 2006;47 5:376–384. [PubMed]
  • Holtom N, Barraclough J. Is the Hospital Anxiety and Depression Scale (HADS) useful in assessing depression in palliative care. Palliat Med. 2000;14 3:219–220. [PubMed]
  • Hotopf M, Chidgey J, Addington-Hall J, Ly KL. Depression in advanced disease: a systematic review – Part 1. Prevalence and case finding. Palliat Med. 2002;16 2:81–97. [PubMed]
  • Hoyl MT, Alessi CA, Harker JO, Josephson KR, Pietruszka FM, Koelfgen M, Mervis JR, Fitten LJ, Rubenstein LZ. Development and testing of a five-item version of the geriatric depression scale. J Am Geriatr Soc. 1999;47:873–878. [PubMed]
  • Huffman JC, Smith FA, Blais MA, Beiser ME, Januzzi JL, Fricchione GL. Rapid screening for major depression in post-myocardial infarction patients: an investigation using Beck Depression Inventory II items. Heart. 2006;92:1656–1660. [PMC free article] [PubMed]
  • Hürny C, Bernhard J, Coates A, Peterson HF, Castiglione-Gertsch M, Gelber RD, Rudenstam CM, Collins J, Lindtner J, Goldhirsch A, Senn HJ. Responsiveness of a single-item indicator vs a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial. Med Care. 1996;34 3:234–248. [PubMed]
  • Irwig L, Macaskill P, Glasziou P, Fahey M. Meta-analytic methods for diagnostic test accuracy. J Clin Epidemiol. 1995;48:119–130. [PubMed]
  • Jefford M, Mileshkin L, Richards K, Thomson J, Matthews JP, Zalcberg J, Jennens R, McLachlan S-A, Wein S, Antill Y, Clarke DM. Rapid screening for depression–validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients. Br J Cancer. 2004;91 5:900–906. [PMC free article] [PubMed]
  • Kadan-Lottick NS, Vanderwerker LC, Block SD, Zhang BH, Prigerson HG. Psychiatric disorders and mental health service use in patients with advanced cancer–a report from the coping with cancer study. Cancer. 2005;104 12:2872–2881. [PMC free article] [PubMed]
  • Kawase E, Karasawa K, Shimotsu S, Imasato S, Ito K, Matsuki H, Sakano Y, Horikawa N. Evaluation of a one-question interview for depression in a radiation oncology department in Japan. Gen Hosp Psychiatry. 2006;28 4:321–322. [PubMed]
  • Kennard BD, Stewart SM, Olvera R, Bawdon RE, O'hAilin A, Lewis CP, Winick NJ. Nonadherence in adolescent oncology patients: preliminary data on psychological risk factors and relationships to outcome. J Clin Psychol Med Settings. 2004;11:30–39.
  • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174. [PubMed]
  • Lawrie I, Lloyd-Williams M, Taylor F. How do palliative medicine physicians assess and manage depression. Palliat Med. 2004;18 3:234–238. [PubMed]
  • Le Fevre P, Devereux J, Smith S, Lawrie SM, Cornbleet M. Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med. 1999;13:399–407. [PubMed]
  • Lloyd-Williams M, Dennis M, Taylor F. A prospective study to compare three depression screening tools in patients who are terminally ill. Gen Hosp Psychiatry. 2004;26 5:384–389. [PubMed]
  • Lloyd-Williams M, Dennis M, Taylor F, Baker I. Is asking patients in palliative care – are you depressed – appropriate? Prospective study. BMJ. 2003a;327:372–373. [PMC free article] [PubMed]
  • Lloyd-Williams M, Friedman T, Rudd N. An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage. 2001;22 6:990–996. [PubMed]
  • Lloyd-Williams M, Riddleston H. The stability of depression scores in patients who are receiving palliative care. J Pain Symptom Manage. 2002;24 6:593–597. [PubMed]
  • Lloyd-Williams M, Shiels C, Dowrick C. The development of the Brief Edinburgh Depression Scale (BEDS) to screen for depression in patients with advanced cancer. J Affect Disord. 2007;99 1–3:259–264. [PubMed]
  • Lloyd-Williams M, Spiller J, Ward J. Which depression screening tools should be used in palliative care. Palliat Med. 2003b;17 1:40–43. [PubMed]
  • Love AW, Grabsch B, Clarke DM, Bloch S, Kissane DW. Screening for depression in women with metastatic breast cancer: a comparison of the Beck Depression Inventory Short Form and the Hospital Anxiety and Depression Scale. Aust N Z J Psychiatry. 2004;38 7:526–531. [PubMed]
  • McIntyre RS, Konarski JZ, Mancini DA, Fulton KA, Parikh SV, Grigoriadis S, Grupp LA, Bakish D, Filteau MJ, Gorman C, Nemeroff CB, Kennedy SH. Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. CMAJ. 2005;173 11:1327–1334. [PMC free article] [PubMed]
  • Meyer HA, Sinnott C, Seed PT. Depressive symptoms in advanced cancer. Part 1. Assessing depression: the Mood Evaluation Questionnaire. Palliat Med. 2003;17:596. [PubMed]
  • Midgette AS, Stukel TA, Littenberg B. A meta-analytic method for summarising diagnostic test performance: receiver operating characteristic summary point estimates. Med Decis Making. 1993;13:253–257. [PubMed]
  • Miller RD, Walsh TD. Psychosocial aspects of palliative care in advanced cancer. J Pain Symptom Manage. 1991;6:24–29. [PubMed]
  • Mitchell AJ. Predictive summary index and other summary measures of diagnostic accuracy 2009. In The Encyclopedia of Medical Decision Making. Kattan M, Sage (in press)
  • Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorder. J Clin Oncol. 2007;25:4670–4681. [PubMed]
  • Mitchell AJ, Coyne JC. Do ultra-short screening instruments accurately detect depression in primary care. Br J Gen Pract February. 2007;57:144–151. [PMC free article] [PubMed]
  • Mitchell AJ, Kaar S, Coggan C, Herdman J. Acceptability of common screening methods used to detect distress and related mood disorders-preferences of cancer specialists and non-specialists. Psychooncology. 2008;17 3:226–236. [PubMed]
  • Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet. 1999;354 9193:1896–1900. [PubMed]
  • Murphy JM. Symptom scales and diagnostic schedules in adult psychiatry Textbook of Psychiatric Epidemiology 2002. John Wiley & Sons Inc.273–332.332In: Ming T Tsuang and Mauricio Tohen (eds)2nd edn, Chapter 12, ppWiley-Liss, ISBN 0-471-40974-X
  • Ng K, von Gunten CF. Symptoms and attitudes of 100 consecutive patients admitted to an acute hospice/palliative care unit. J Pain Symptom Manage. 1998;16:307–315. [PubMed]
  • Noorani NH, Montagnini M. Recognizing depression in palliative care patients. J Palliat Med. 2007;10 2:458–464. [PubMed]
  • Ohno T, Noguchi W, Nakayama Y, Kato S, Tsujii H, Suzuki Y. How do we interpret the answer neither when physicians ask patients with cancer ‘are you depressed or not?'. J Pall Med. 2006;9 4:861–865. [PubMed]
  • Pai M, McCulloch M, Enanoria W, Colford JM. Systematic reviews of diagnostic test evaluations: what's behind the scenes. Evid Based Med. 2004;9:101–103.
  • Pallant JF, Miller RL, Tennant A. Evaluation of the Edinburgh Postnatal Depression Scale using Rasch analysis. BMC Psychiatry. 2006;6:28. [PMC free article] [PubMed]
  • Pascoe S, Edelman S, Kidman A. Prevalence of psychological distress and use of support services by cancer patients at Sydney Hospitals. Aust N Z J Psychiatry. 2000;34:785–791. [PubMed]
  • Payne A, Barry S, Creedon B, Stone C, Sweeney C, O'Brien T, O'Sullivan K. Sensitivity and specificity of a two-question screening tool for depression in a specialist palliative care unit. Palliat Med. 2007;21:193–198. [PubMed]
  • Pratheepawanit N, Salek MS, Finlay IG. The applicability of quality-of-life assessment in palliative care: combining two quality-of-life measures. Palliat Med. 1999;13:325–334. [PubMed]
  • Reuter K, Raugust S, Bengel J, Harter M. Depressive symptom patterns and their consequences for diagnosis of affective disorders in cancer patients. Suppor Care Cancer. 2004;12 12:864–870. [PubMed]
  • Robinson JA, Crawford GB. Identifying palliative care patients with symptoms of depression: an algorithm. Palliat Med. 2005;19 4:278–287. [PubMed]
  • Serrano-Duen M, Soledad SM. Concurrent validation of the 21-item and 6-item Hamilton Depression Rating Scale vs the DSM-IV diagnostic criteria to assess depression in patients with Parkinson's disease: an exploratory analysis. Parkinsonism Relat Disord. 2008;14 3:233–238. [PubMed]
  • Sharpe M, Strong V, Allen K, Rush R, Postma K, Tulloh A, Maguire P, House A, Ramirez A, Culi A. Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer. 2004;90:314–320. [PMC free article] [PubMed]
  • Skarstein J, Aass N, Fossa SD, Skovlund E, Dahl AA. Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. J Psychosom Res. 2000;49:27–34. [PubMed]
  • Sollner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G, Maislinger S. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling. Br J Cancer. 2001;84 2:179–185. [PMC free article] [PubMed]
  • Spitzer RL, Kurt Kroenke K, Williams JBW, the Patient Health Questionnaire Primary Care Study Group Validation and Utility of a Self-report Version of PRIME-MD. The PHQ Primary Care Study. JAMA. 1999;282:1737–1744. [PubMed]
  • Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol. 2002;20 14:3137–3148. [PubMed]
  • Steer RA, Cavalieri TA, Leonard DM, Beck AT. Use of the beck depression inventory for primary care to screen for major depression disorders. Gen Hosp Psychiatry. 1999;21:106–111. [PubMed]
  • Stiefel F, Trill MD, Berney A, Olarte JMN, Razavi D. Depression in palliative care: a pragmatic report from the expert working group of the European Association for Palliative Care. Support Care Cancer. 2001;9 7:477–488. [PubMed]
  • Thekkumpurath P, Venkateswaran C, Kumar M, Bennett M. Screening for psychological distress in palliative care: validation of screening questionnaires in a hospice population in Leeds Psychooncology 2007. 169S257(Suppl. S)
  • Trask P. Assessment of depression in cancer patients. J Natl Cancer Inst. 2004;2004 32:80–92. [PubMed]
  • van Marwijk HW, Wallace P, de Bock GH, Hermans J, Kaptein AA, Mulder JD. Evaluation of the feasibility, reliability and diagnostic value of shortened versions of the geriatric depression scale. Br J Gen Pract. 1995;45 393:195–199. [PMC free article] [PubMed]
  • Vignaroli E, Pace EA, Willey J, Palmer JL, Zhang T, Bruera E. The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med. 2006;9 2:296–303. [PubMed]
  • Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of distress by cancer site. Psychooncology. 2001;10:19–28. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...